AFX • Carl Zeiss Meditec AG • XETRA LONG TF H4#AFX • Carl Zeiss Meditec AG • XETRA LONG TF H4,
TP = 98.90 , SL = 72.48
The trend continues, the nearest support level according to my calculations TP = 98.90
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.17 USD
309.74 M USD
2.23 B USD
About CARL ZEISS MEDITEC AG
Sector
Industry
CEO
Markus Weber
Website
Headquarters
Jena
Founded
1995
FIGI
BBG000J0P812
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Strategic Business Unit (SBU) and Microsurgery business SBU segments. The Ophthalmic SBU segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery SBU segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded in 2002 and is headquartered in Jena, Germany.
Did Carl Zeiss found the ground?Carl Zeiss hits a strong resistance line and at the same time the lower end of the downward trend channel. Also the RSI was extremly negative and is now raising.
If the price can escape the downtrend channel to the upside, a potential long-term uptrend might be imminent
AFX short to 140. w24 2021.Weekly
Uptrend fast
Daily
In upper channel
4h
Clear divergency on RSI
I will wait for long correction. Seems better short
Open 165
SL 175
TP 140
RR 3
However, I think that company has bright feature and will gain profit after.
CARL ZEISS MEDITEC 100 EURO BUYING ZONEIf the price drop down near 100 EURO, this is a support level and an excellent buying zone. Wait and listen:)
AFX symmetrical consolidation potential break thru resistance on after symmetrical consolidation P:L, 1:3R
or
potential downtrend after hitting resistance and breaking thru support P:L, 1:3R
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.